Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids.
Journal: SLAS discovery : advancing life sciences R & D
Published: November 30, 2024
Aplastic anemia secondary to dual cancer immunotherapies a physician nightmare: case report and literature review.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: March 08, 2021
Circulating tumor DNA analysis in the era of precision oncology.
Journal: Oncotarget
Published: August 01, 2019
Defining, Identifying, and Understanding "Exceptional Responders" in Oncology Using the Tools of Precision Medicine.
Journal: Cancer journal (Sudbury, Mass.)
Published: July 24, 2019
Basket Trials and the MD Anderson Precision Medicine Clinical Trials Platform.
Journal: Cancer journal (Sudbury, Mass.)
Published: July 24, 2019
Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations.
Journal: World journal of urology
Published: May 21, 2019
Chronic Myeloid Leukemia in a Patient Receiving Tofacitinib: A Case Report and Literature Review.
Journal: Case reports in rheumatology
Published: February 24, 2019
Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits.
Journal: Expert opinion on investigational drugs
Published: January 23, 2018
Obinutuzumab for the treatment of chronic lymphocytic leukemia and other B-cell lymphoproliferative disorders.
Journal: Expert opinion on biological therapy
Published: September 13, 2017
Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancer.
Journal: Cancer chemotherapy and pharmacology
Published: February 01, 2016
Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancer.
Journal: Cancer chemotherapy and pharmacology
Published: November 17, 2015
Last Updated: 09/26/2026